Moderna reports Covid vaccine, in trial at SLU, is 95% effective, can be stored at higher temperatures

The Massachusetts-based biotech firm says an early look at data from its Covid-19 vaccine's phase 3 trial, in which Saint Louis University is participating, shows it may be more effective than Pfizer’s leading candidate at preventing infection and will be easier to distribute.